Literature DB >> 797533

Blocking and unblocking serum factors in neoplasia.

S C Bansal, B R Bansal, J P Boland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 797533     DOI： 10.1007/978-3-642-66530-1_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  6 in total

1.  Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus.

Authors:  K A Schat; B W Calnek
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  Immunologic enhancement of experimental metastasis in the rat.

Authors:  J R Starkey; S S Ristow; T L McDonald; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.

Authors:  R W Engelman; R D Tyler; L Q Trang; W T Liu; R A Good; N K Day
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

5.  Treatment of advanced malignancy with plasma perfused over staphylococcal protein A.

Authors:  F R MacKintosh; K Bennett; S Schiff; J Shields; S W Hall
Journal:  West J Med       Date:  1983-07

6.  [Limits and possibilities of neoplasm immunotherapy].

Authors:  R Kurth
Journal:  Naturwissenschaften       Date:  1978-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.